July 21, 2020 by Chain Drug Review
Greg Wasson, Innovation Associates, OptimizeRx Corp.
Supplier News

ROCHESTER, Mich. — OptimizeRx Corp. has appointed Greg Wasson, former president and CEO of Walgreen Boots Alliance, to its board of directors. “Consumer awareness of digital health services, and especially the need for better affordability and adherence, has never been greater,” said OptimizeRx CEO and director, William Febbo. “Our platform delivers for the life sciences
April 7, 2020 by Chain Drug Review
Greg Wasson, Innovation, Marvin Richardson, Mary Reno
Leading Headlines, Supplier News, Technology

JOHNSON CITY, N.Y. – Innovation announced on Tuesday that Marvin Richardson will become the company’s chief executive officer effective April 25th. Richardson replaces Mary Reno, who has served as the chief executive officer since 1998. Ms. Reno will continue to serve on the company’s board of directors as chairwoman emeritus. Richardson has served as co-president
November 13, 2019 by Chain Drug Review
Allomer Capital Group, Greg Wasson, Innovation, Innovation Associates, Marvin Richardson, Mary Reno, pharmacy automation offerings, Steve Chang, Wasson Enterprise
Leading Headlines, Pharmacy, Supplier News, Technology

JOHNSON CITY, N.Y. – Innovation Associates, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, government, and mail order pharmacy markets, announced Wednesday the signing of a definitive agreement pursuant to which a consortium of investors led by Greg Wasson, the former Walgreens Boots Alliance chief executive officer, will
April 21, 2017 by Chain Drug Review
Greg Wasson, Innventure, Innventure — a Wasson Enterprise Partnership, Michael Otworth, Walgreens, Walgreens Boots Alliance, Wasson Enterprise
Business, Leading Headlines, Retail News

CHICAGO — Former Walgreens Boots Alliance chief executive officer Greg Wasson is part of a joint venture to help Fortune 50 companies take advantage of disruptive technologies with significant market potential. Wasson Enterprise, a Chicago-based angel investment group founded by Wasson, and Innventure, co-founded by entrepreneur Michael Otworth to commercialize innovative technology, have formed Innventure —
May 18, 2015 by Mark Baumgartner and Chain Drug Review
Bayer Consumer Care, David Heist, Energizer Holdings, Greg Wasson, Lou Martire, NACDS, National Association of Chain Drug Stores, Robert B. Begley Award, Sheldon W. Fantle Lifetime Achievement Award, Walgreens
2015, Issue 05-18-2015, News
PALM BEACH, Fla. — The National Association of Chain Drug Stores bestowed the chain drug industry’s highest honors on three “industry icons” at its annual meeting here last month. Greg Wasson, former president and chief executive officer of Walgreen Co., received the Sheldon W. Fantle Lifetime Achievement Award. Two industry veterans received the Robert B.
April 29, 2015 by Chain Drug Review and Chain Drug Review
Bayer Consumer Care, David Heist, Energizer Holdings, Greg Wasson, Lou Martire, NACDS Annual Meeting, National Association of Chain Drug Stores, Robert B. Begley Award, Sheldon W. Fantle Lifetime Achievement Award, Steve Anderson, Walgreens
Featured Articles, Leading Headlines, Retail News

PALM BEACH, Fla. — Former Walgreen Co. president and chief executive officer Greg Wasson received the Sheldon W. Fantle Lifetime Achievement Award, the chain drug industry’s top honor, from the National Association of Chain Drug Stores last night at the NACDS Annual Meeting. Also on Tuesday evening, NACDS presented David Heist, director of industry affairs
February 2, 2015 by John Schultz and Chain Drug Review
AmerisourceBergen, board of directors, Greg Wasson, Ornella Barra, Richard Gozon, Steven Collis, Walgreens, Walgreens Boots Alliance
2015, Issue 02-02-2015, News
VALLEY FORGE, Pa. — Ornella Barra, executive vice president of Walgreens Boots Alliance Inc. (WBA), has been elected to the board of directors at AmerisourceBergen Corp. Barra, who also serves as president and chief executive officer of global wholesale and international retail, fills the vacancy created by Greg Wasson’s resignation from the board on January 9.
January 19, 2015 by Mark Tosh and Chain Drug Review
Alliance Boots, CEO search, Greg Wasson, Jim Skinner, Nasdaq, Nasdaq MarketSite, Stefano Pessina, Walgreen Co., Walgreens Boots Alliance, WBA
2015, Issue 01-19-2015, News

NEW YORK — Walgreens Boots Alliance Inc.’s (WBA’s) top executives marked the close of a busy first week as a new company by ringing the opening bell January 9 at the Nasdaq Stock Market, where the company now trades under the “WBA” ticker symbol. Moments later, in an interview with financial network CNBC, executive vice chairman
January 9, 2015 by Chain Drug Review and Chain Drug Review
Greg Wasson, Jim Skinner, Nasdaq, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, CDR Blog

Possibly lost in the fanfare surrounding the formal debut of Walgreens Boots Alliance, and its new home on the Nasdaq stock exchange, is the company’s new logo. Jim Skinner, executive chairman of WBA (the new stock symbol, by the way), told CNBC in the wake of the Nasdaq launch event in Manhattan that the company’s globe-shape logo
January 5, 2015 by Chain Drug Review
Alliance Boots, Dominic Murphy, Greg Wasson, Jim Skinner, KKR, merger, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens shareholders, WBA
Business, Featured Articles, Retail News

DEERFIELD, Ill. – As expected, Walgreen Co. and Alliance Boots GmbH have finalized the second step of their two-part merger agreement following Walgreens shareholders’ approval earlier this week. Coming just before the new year, the completion of the deal announced in 2012 reorganizes Walgreens into a subsidiary of a new holding company, Walgreens Boots Alliance
January 5, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, Chain Drug Review, Greg Wasson, Kermit Crawford, Ronald L. Ziegler Lifetime Achievement Award, Walgreens
2015, Issue 01-05-2015, News

DEERFIELD, Ill. — Kermit Crawford, who retired as Walgreen Co.’s president of pharmacy, health and wellness on December 31, ended his career at Walgreens the same way he began it 31 years ago — providing the best in patient care. Building on the ethos instilled in him by his mother, Doris Crawford, while he was
January 5, 2015 by Mark Tosh and Chain Drug Review
Alliance Boots, Greg Wasson, James Skinner, Stefano Pessina, Walgreens, Walgreens Boots Alliance, William Foote
2015, Business, Issue 01-05-2015, News
DEERFIELD, Ill. — The New Year ushered in the beginning of a new era at Walgreen Co., which is scheduled to complete the second and final step of its merger with Alliance Boots GmbH in the first quarter. And this new era for Walgreens Boots Alliance will get under way without the presence of longtime
January 5, 2015 by David Pinto and Chain Drug Review
Alliance Boots, AmerisourceBergen, Bartell Drugs, Cardinal Health, chain drug industry, chain drug retailing, CVS Health, David Pinto, Greg Wasson, Kerr Drug, National Association of Chain Drug Stores, Rite Aid, Tony Civello, Walgreens, Walgreens Boots Alliance
2015, Issue 01-05-2015, Opinion
Which events were most significant for chain drug retailing in 2014? As usual, that is not an easy question to answer. In many ways, 2014 was a remarkable year for the chain drug industry, one in which the character of the business was changed, probably irrevocably. The industry assumed a global character for perhaps the
January 5, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, CEO, chief executive officer, drug chain, Greg Wasson, Jeffrey Woldt, retail pharmacy, Stefano Pessina, Walgreens
2015, Issue 01-05-2015, Opinion
When the history of Walgreen Co. is written, Greg Wasson, who last month announced that he would step down as chief executive officer of the drug chain upon completion of its merger with Alliance Boots, will be seen as one of the company’s most consequential leaders. A product of the Walgreens system who joined the